Low Gene Dosage of Cdc42 Is Not Associated with Protein Dysfunction in Patients with Colorectal Cancer
- 1 December 2016
- journal article
- research article
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 35 (12) , 819-827
Abstract
High incidence of Rho Cdc42-GTPase overexpression has been found in Colorectal Cancer (CRC) samples, suggesting its potential role in tumor development. However, no conclusive studies have shown the lack of mutations and/or copy number of Cdc42 gene in this type of samples. To understand mutation/deletion and copy number status of Cdc42 gene, CRC patients were evaluated for both parameters. More than Cdc42 mutants, single-nucleotide variants were found. Analysis of regions flanking the Cdc42 gene showed allelic imbalance; 58.7% were loss of heterozygosity (LOH) positive and 14.8% presented microsatellite instability. The highest LOH percentage was located between microsatellite markers D1S199 and D1S2674, where the Cdc42 gene is located. No association between gender, age, and tumor stage was found. LOH validation through gene dosage analysis showed most CRC patients with allelic imbalance also presented a low gene dosage of Cdc42, although equal amounts of Cdc42 mRNA were detected in all samples. Although changes in Cdc42 expression were not found in any condition, Cdc42 activation was different between high and normal gene dosage samples, but not between samples with normal and low copy number. Low dosage of Cdc42 was also not related to changes in methylation status at the Cdc42 promoter region. Results suggest that low copy of Cdc42 gene is not associated with Cdc42 protein dysfunction in CRC patients.Keywords
This publication has 42 references indexed in Scilit:
- The Quest for the1p36Tumor SuppressorCancer Research, 2008
- DNA methylation and gene silencing in cancerNature Clinical Practice Oncology, 2005
- The challenges of abundance: epithelial junctions and small GTPase signallingCurrent Opinion in Cell Biology, 2005
- Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancerHuman Molecular Genetics, 2001
- Distal deletion of 1p in colorectal tumorsCancer Genetics and Cytogenetics, 2001
- Allelic imbalance and cytogenetic deletion of 1p in colorectal adenomas: A target region identified between DIS199 and DIS234Genes, Chromosomes and Cancer, 1998
- Cytogenetic findings in metastases from colorectal cancerInternational Journal of Cancer, 1997
- Chromosome abnormalities in colorectal adenomas: Two cytogenetic subgroups characterized by deletion of 1 p and numerical aberrationsHuman Pathology, 1996
- Clonal karyotypic abnormalities in colorectal adenomas: Clues to the early genetic events in the adenoma‐carcinoma sequenceGenes, Chromosomes and Cancer, 1994
- Integrated human genome–wide maps constructed using the CEPH reference panelNature Genetics, 1994